Fig. 2

Plasma cytokine and chemokine concentrations in TBI patients stratified according to the 6-month GOSE. I nterleukin (IL)-1β, -10, tumor necrosis factor (TNF)-α (a–c). IL-8, monocyte chemoattractant protein (MCP)-1, macrophage-derived chemokine (MDC) (d–f) in TBI patients with unfavorable (GOSE 1–4, n = 102) vs. favorable (GOSE 5–8, n = 61) 6-month neurological outcome. Lines represent the median and interquartile range. ^* p < 0.05 vs. favorable outcome by Mann-Whitney U test